Viral Induced Asthma Exacerbations

病毒引起的哮喘加重

基本信息

  • 批准号:
    7824755
  • 负责人:
  • 金额:
    $ 0.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2009-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Viral respiratory tract infections are an important cause of asthma exacerbations. Rhinoviruses (RV) are the most common type detected in these patients. We have evidence that RV infect the lower airway, and stimulate the generation of proinflammatory mediators leading to recruitment of neutrophils which then cause airway injury including epithelial damage and increased mucus secretion. These changes result in airway obstruction, hyper-responsiveness and increased asthma symptoms. Since asthma exacerbations develop only in a subset of asthma patients who suffer a viral respiratory tract infection, host susceptibility factors including decreased generation of antiviral factors or increased release of proinflammatory mediators have been suspected to play a role in the pathogenesis of these attacks. We therefore, hypothesize that virus-induced asthma exacerbation (VIAX) with RV infections are the result of enhanced neutrophil recruitment and activation in the lower airway with subsequent intraluminal airway obstruction and airway parenchymal uncoupling. We further propose that this enhanced neutrophilic inflammatory response is seen in a subset of asthma patients with altered antiviral responses and increased generation of proinflammatory responses to RV. To test this hypothesis we will determine the physiological consequences of VIAX on lung function including intraluminal bronchial obstruction and airway-parenchymal uncoupling. We will also use radiological imaging with CT scans, 3He-MRI, and 18FDG PET to determine the functional and structural changes in the lung during VIAX and to determine the relationship of these changes to observed pulmonary physiology. Finally we will determine the mechanisms of lower airway inflammation associated with the VIAX by analysis of sputum and bronchial lavage cells and mucosal biopsies, determine the relationship of these virus-induced effects to airflow obstruction and lung structure, and begin to determine the genetic host susceptibility factors that may regulate these processes. From these observations, we will be able to better define the mechanisms of VIAX and hopefully help develop improved treatment.
描述(由申请人提供):病毒性呼吸道感染是哮喘加重的重要原因。鼻病毒(RV)是这些患者中最常见的病毒类型。 我们有证据表明,RV 感染下呼吸道,并刺激促炎介质的产生,导致中性粒细胞募集,从而导致气道损伤,包括上皮损伤和粘液分泌增加。这些变化导致气道阻塞、高反应性和哮喘症状加重。由于哮喘恶化仅发生在遭受病毒性呼吸道感染的哮喘患者中,因此宿主易感因素(包括抗病毒因子产生减少或促炎介质释放增加)被怀疑在这些发作的发病机制中发挥作用。因此,我们假设 RV 感染引起的病毒性哮喘急性发作 (VIAX) 是下气道中性粒细胞募集和激活增强以及随后的管腔内气道阻塞和气道实质解偶联的结果。我们进一步提出,这种增强的中性粒细胞炎症反应可见于抗病毒反应改变和对 RV 的促炎症反应产生增加的哮喘患者亚群中。为了检验这一假设,我们将确定 VIAX 对肺功能的生理影响,包括管腔内支气管阻塞和气道实质解偶联。我们还将使用 CT 扫描、3He-MRI 和 18FDG PET 放射成像来确定 VIAX 期间肺部的功能和结构变化,并确定这些变化与观察到的肺部生理学的关系。 最后,我们将通过分析痰液和支气管灌洗细胞以及粘膜活检来确定与 VIAX 相关的下气道炎症机制,确定这些病毒诱导的效应与气流阻塞和肺结构的关系,并开始确定可能调节这些过程的遗传宿主易感性因素。根据这些观察结果,我们将能够更好地定义 VIAX 的机制,并希望有助于开发改进的治疗方法。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C.
  • DOI:
    10.1038/nm.2358
  • 发表时间:
    2011-05
  • 期刊:
  • 影响因子:
    82.9
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NIZAR N JARJOUR其他文献

NIZAR N JARJOUR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NIZAR N JARJOUR', 18)}}的其他基金

Investigating the mechanisms by which systemic inflammation promotes Alzheimer’s disease: Asthma as a model and modifiable risk factor
研究全身炎症促进阿尔茨海默病的机制:哮喘作为模型和可改变的危险因素
  • 批准号:
    10661382
  • 财政年份:
    2023
  • 资助金额:
    $ 0.89万
  • 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
  • 批准号:
    8175591
  • 财政年份:
    2011
  • 资助金额:
    $ 0.89万
  • 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
  • 批准号:
    8849951
  • 财政年份:
    2011
  • 资助金额:
    $ 0.89万
  • 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
  • 批准号:
    8496108
  • 财政年份:
    2011
  • 资助金额:
    $ 0.89万
  • 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
  • 批准号:
    8680346
  • 财政年份:
    2011
  • 资助金额:
    $ 0.89万
  • 项目类别:
Stability of Severe Asthma Phenotypes: Impact of Exacerbations
严重哮喘表型的稳定性:恶化的影响
  • 批准号:
    8315751
  • 财政年份:
    2011
  • 资助金额:
    $ 0.89万
  • 项目类别:
Role of Eosinophils in T-Cells Function and Remodeling
嗜酸性粒细胞在 T 细胞功能和重塑中的作用
  • 批准号:
    7843278
  • 财政年份:
    2009
  • 资助金额:
    $ 0.89万
  • 项目类别:
Administrative core
行政核心
  • 批准号:
    7843284
  • 财政年份:
    2009
  • 资助金额:
    $ 0.89万
  • 项目类别:
Role of Eosinophils in Airway Inflammation and Remodeling
嗜酸性粒细胞在气道炎症和重塑中的作用
  • 批准号:
    7824378
  • 财政年份:
    2009
  • 资助金额:
    $ 0.89万
  • 项目类别:
Role of Eosinophils in Airway Inflammation and Remodeling
嗜酸性粒细胞在气道炎症和重塑中的作用
  • 批准号:
    7760624
  • 财政年份:
    2008
  • 资助金额:
    $ 0.89万
  • 项目类别:

相似海外基金

Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
  • 批准号:
    494286
  • 财政年份:
    2023
  • 资助金额:
    $ 0.89万
  • 项目类别:
    Operating Grants
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
  • 批准号:
    10364056
  • 财政年份:
    2022
  • 资助金额:
    $ 0.89万
  • 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
  • 批准号:
    10621913
  • 财政年份:
    2022
  • 资助金额:
    $ 0.89万
  • 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
  • 批准号:
    10373627
  • 财政年份:
    2022
  • 资助金额:
    $ 0.89万
  • 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
  • 批准号:
    10553146
  • 财政年份:
    2022
  • 资助金额:
    $ 0.89万
  • 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE介导的单核细胞抗病毒反应途径的调节机制
  • 批准号:
    10640247
  • 财政年份:
    2021
  • 资助金额:
    $ 0.89万
  • 项目类别:
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
AMPK 和 Hippo 信号传导之间的相互作用调节眼部对寨卡病毒感染的抗病毒反应
  • 批准号:
    10322026
  • 财政年份:
    2021
  • 资助金额:
    $ 0.89万
  • 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE 介导的单核细胞抗病毒反应途径调节机制
  • 批准号:
    10438876
  • 财政年份:
    2021
  • 资助金额:
    $ 0.89万
  • 项目类别:
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
抗病毒反应与转座子去抑制在阿尔茨海默病和衰老中的作用
  • 批准号:
    10629440
  • 财政年份:
    2021
  • 资助金额:
    $ 0.89万
  • 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
  • 批准号:
    10373575
  • 财政年份:
    2021
  • 资助金额:
    $ 0.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了